Dr. Matthew A. Agee
Radiology (Diagnostic Radiology Physician)
- Medicare participating
At a glance
- Years since graduation
- 8
- In the NPI registry since
- 2018
- Medicare patients seen, 2024
- 1,769
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2018Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Diagnostic Radiology Physician primary
NY license 318666-01
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- New York-Presbyterian Hospital New York, NY
- Hospital for Special Surgery New York, NY
Medical groups
- Weill Medical College of Cornell (2,051 clinicians)
- Kings Physician Services PC (648 clinicians)
- Weill Cornell Imaging at New York Presbyterian (150 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,769
- Services billed
- 4,001
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Dxa bone density measurement of hip, pelvis, spine | 811 | 811 |
| Calculation of trabecular bone score (tbs) using imaging data with interpretation and report on fracture risk | 805 | 805 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 400 | 376 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 230 | 213 |
| Piflufolastat f-18, diagnostic, 1 millicurie | 199 | 21 |
| Nuclear medicine study of bone and/or joint whole body | 90 | 73 |
| Gallium ga-68 gozetotide, diagnostic, (illuccix), 1 millicurie | 84 | 15 |
| Nuclear medicine study whole body with ct scan | 64 | 62 |
| Nuclear medicine study, spect imaging with concurrent ct scan, 1 area or single acquisition, single day imaging | 48 | 47 |
| Nuclear medicine study of lymphatic system | 45 | 45 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 4 companies reported 5 payments worth $332 in total to this clinician.
| Telix Pharmaceuticals | $138 |
|---|---|
| GE Healthcare | $105 |
| Novartis Pharmaceuticals Corporation | $61.86 |
| Progenics Pharmaceuticals, Inc. | $27.73 |
| Food and Beverage | $332 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.